Crit Rev Food Sci Nutr. 2013 Oct 2. [Epub ahead of print]
Borel P 1, Caillaud D, Cano NJ.
1a INSERM, UMR1062, Nutrition, Obesity and Risk of Thrombosis , F-13385 , Marseille , France.
There has been renewed interest in vitamin D since numerous recent studies have suggested that besides its well-established roles in bone metabolism and immunity, vitamin D status is inversely associated with the incidence of several diseases, e.g. cancers, cardio-vascular diseases and neurodegenerative diseases. Surprisingly, there is very little data on factors that affect absorption of this fat-soluble vitamin, although it is acknowledged that dietary vitamin D could help to fight against the sub-deficient vitamin D status that is common in several populations. This review describes the state of the art concerning the fate of vitamin D in the human upper gastrointestinal tract and on the factors assumed to affect its absorption efficiency. The main conclusions are:
- (i) ergocalciferol (vitamin D2), the form mostly used in supplements and fortified foods, is apparently absorbed with similar efficiency to cholecalciferol (vitamin D3, the main dietary form),
- (ii) 25-hydroxyvitamin D (25OHD), the metabolite produced in the liver, and which can be found in foods, is better absorbed than the non-hydroxy vitamin D forms cholecalciferol and ergocalciferol,
- (iii) the amount of fat with which vitamin D is ingested does not seem to significantly modify the bioavailability of vitamin D3,
- (iv) the food matrix has apparently little effect on vitamin D bioavailability,
- (v) sucrose polyesters (Olestra) and tetrahydrolipstatin (orlistat) probably diminish vitamin D absorption, and
- (vi) there is apparently no effect of ageing on vitamin D absorption efficiency.
We also find that there is insufficient, or even no data on the following factors suspected of affecting vitamin D:
- (i) effect of type and amount of dietary fibre,
- (ii) effect of vitamin D status, and
- (iii) effect of genetic variation in proteins involved in its intestinal absorption.
In conclusion, further studies are needed to improve our knowledge of factors affecting vitamin D absorption efficiency. Clinical studies with labelled vitamin D, e.g. deuterated or 13C, are needed to accurately and definitively assess the effect of various factors on its bioavailability.
PMID: 24915331
Download the PDF from VitaminDWiki obtained from Researchgate
Does not appear to cover the following bio-availability issues
Forms: oil, powder, bio-mulsion, spray, topical, sublingual
Gut problems
Missing Gall Bladder
Too little Magnesium
Poor ratio of Omega-3 to Omega-6
Too much Vitamin A
Time of day
Dose frequency – e.g. daily, weekly, monthly
Note; all of these issues are described in VitaminDWiki
Warning: Several of their conclusions are based on very small studies (20 people) and/or Vitamin D2
See also VitaminDWiki
- Search VitaminDWiki for BIO_AVAILABILITY 568 items as of Dec 2015
- Vitamin D bioavailability is associated with cholesterol – Jan 2011
- Vitamin D bioavailability in the gut– review Sept 2017
- Review of bioavailability of vitamin D - oil aprox 2 ng per 100 IU Sept 2010
- Gut-Friendly Vitamin D
- Nanoencapsulated vitamin D is stable and bioavailable – May 2012
- How you might double your response to vitamin D
- Low cost cofactors for vitamin D
provides best guesses of how much each co-factor increases Vitamin D - Sublingual vitamin D
- Oil-based Vitamin D3 has the worst bioavailability – April 2014
- Increasing the ratio of mono to poly fats increased Vitamin D levels by 6 ng – RCT Aug 2011
- Pharmacology of vitamin D - April 2011
". . . is between 60 and 99 %, if given with milk, long-chain fatty acid containing triglycerides or a "standard meal". - All items in category Forms of Vitamin D
113 items - Vitamin D reduced so low that Victorian age diseases are returning
has the following chart - showing Mg, etc.Printer Friendly Follow this page for updates10838 visitors, last modified 23 Sep, 2017, - Vitamin D reduced so low that Victorian age diseases are returning